Espacio reservado para banners y logos institucionales

SABER UCV >  1) Investigación >  Artículos Publicados > 

> Aziridine-2,3-Dicarboxylates, Peptidomimetic Cysteine Protease Inhibitors with Antileishmanial Activity
Please use this identifier to cite or link to this item: https://saber.ucv.ve/handle/10872/1701

Title: Aziridine-2,3-Dicarboxylates, Peptidomimetic Cysteine Protease Inhibitors with Antileishmanial Activity
Authors: Ponte-Sucre, Alicia
Vicik, Radim
Schultheis, Martina
Schirmeister, Tanja
Moll, Heidrun
Keywords: Aziridine-2,3-Dicarboxylates
Cysteine Protease Inhibitors
Leishmania
Issue Date: 23-Aug-2012
Series/Report no.: Antimicrobial Agents and Chemotherapy;50: 2439-2447, 2006
Abstract: serious side effects, and there is a worldwide increasing frequency of chemoresistance to antimonials. These issues emphasize the urgent need for affordable alternative drugs against leishmaniasis. Leishmania cysteine proteases are essential for parasite growth, differentiation, pathogenicity, and virulence and are thus attractive targets for combating leishmaniasis. Herein we demonstrate that the cysteine protease inhibitors aziridine- 2,3-dicarboxylates 13b and 13e impaired promastigote growth at mid-micromolar concentrations and decreased the infection rate of peritoneal macrophages at concentrations 8- to 13-fold lower than those needed to inhibit parasite replication. Simultaneous treatment of infected cells with compound 13b and gamma interferon resulted in an even further reduction of the concentration needed for a significant decrease in macrophage infection rate. Notably, treatment with the compounds alone modulated the cytokine secretion of infected macrophages, with increased levels of interleukin-12 and tumor necrosis factor alpha. Furthermore, the decreased infection rate in the presence of compound 13b correlated with increased nitric oxide production by macrophages. Importantly, at the concentrations used herein, compounds 13b and 13e were not toxic against fibroblasts, macrophages, or dendritic cells. Together, these results suggest that the aziridine-2,3-dicarboxylates 13b and 13e are potential antileishmanial lead compounds with low toxicity against host cells and selective antiparasitic effects.
URI: http://hdl.handle.net/10872/1701
ISSN: 1098-6596
Appears in Collections:Artículos Publicados

Files in This Item:

File Description SizeFormat
Ponte-Sucre et al., AAC 2006.pdf299.54 kBAdobe PDFView/Open
View Statistics

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.